Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse

Pediatric Research

Volumn 78, Issue 5, 2015, Pages 520-526

  Donega, Vanessa ^a   Nijboer, Cora H ^a   Van Velthoven, Cindy T J ^a   Youssef, Sameh A ^b   De Bruin, Alain ^b   Van Bel, Frank ^a   Kavelaars, Annemieke ^c   Heijnen, Cobi J ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; MYELIN BASIC PROTEIN; BIOLOGICAL MARKER; MICROTUBULE ASSOCIATED PROTEIN; MTAP2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; BRAIN INJURY; COGNITION; FEMALE; GRAY MATTER DAMAGE; LONG TERM CARE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NERVOUS SYSTEM PARAMETERS; NEWBORN; NEWBORN DISEASE; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; TURBINATE; WHITE MATTER LESION; ADVERSE EFFECTS; ANIMAL; ANIMAL BEHAVIOR; BRAIN; C57BL MOUSE; CELL CULTURE; CONVALESCENCE; DISEASE MODEL; HYPOXIA-ISCHEMIA, BRAIN; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RECOGNITION; RISK ASSESSMENT; TIME FACTOR;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BIOMARKERS; BRAIN; CELLS, CULTURED; COGNITION; DISEASE MODELS, ANIMAL; HYPOXIA-ISCHEMIA, BRAIN; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; MOTOR ACTIVITY; MYELIN BASIC PROTEIN; RECOGNITION (PSYCHOLOGY); RECOVERY OF FUNCTION; RISK ASSESSMENT; TIME FACTORS;

EID: 84946082257     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2015.145     Document Type: Article

References (19)

1. Dammann O, Ferriero D, Gressens P. Neonatal encephalopathy or hypoxicischemic encephalopathy?. Appropriate terminology matters. Pediatr Res 2011; 70: 1-2
2. De Haan M, Wyatt JS, Roth S, Vargha-Khadem F, Gadian D, Mishkin M. Brain and cognitive-behavioural development after asphyxia at term birth. Dev Sci 2006; 9: 350-8
3. Ferriero DM. Neonatal brain injury. N Engl J Med 2004; 351: 1985-95
4. Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE. A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol 2008; 199: 587-95
5. van Handel M, Swaab H, De Vries LS, Jongmans MJ. Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: a review. Eur J Pediatr 2007; 166: 645-54
6. Wang CC, Chen CH, Lin WW, et al. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. Cardiovasc Res 2008; 77: 515-24
7. Gonzalo-Daganzo R, Regidor C, Martín-Donaire T, et al. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 2009; 11: 278-88
8. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875-84
9. Zhang R, Liu Y, Yan K, et al. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation 2013; 10: 106
10. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28: 585-96
11. Donega V, van Velthoven CT, Nijboer CH, et al. Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS One 2013; 8: e51253
12. Donega V, Nijboer CH, van Tilborg G, Dijkhuizen RM, Kavelaars A, Heijnen CJ. Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury. Exp Neurol 2014; 261: 53-64
13. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun 2011; 25: 1342-8
14. Taylor I. Mouse. In: McInnes EF, ed. Background Lesions in Laboratory Animals. 1st edn. Edinburgh, UK: Saunders Elsevier, 2012: 45-72
15. Ward JM, Goodman DG, Squire RA, Chu KC, Linhart MS. Neoplastic and nonneoplastic lesions in aging (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice. J Natl Cancer Inst 1979; 63: 849-54
16. Tarone RE, Chu KC, Ward JM. Variability in the rates of some common naturally occurring tumors in Fischer 344 rats and (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice. J Natl Cancer Inst 1981; 66: 1175-81
17. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 2010; 30: 9603-11
18. Giuliani M, Fleury M, Vernochet A, et al. Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation. PLoS One 2011; 6: e19988
19. Pluchino S, Cossetti C. How stem cells speak with host immune cells in inflammatory brain diseases. Glia 2013; 61: 1379-401